Page 179 - Vitamin D and Cancer

166 E. Gocek and G.P. Studzinski

42. Gaschott T, Werz O, Steinmeyer A, Steinhilber D, Stein J (2001) Butyrate-induced
differentiation of CaCo-2 cells is mediated by vitamin D receptor. Biochem Biophys Res
Commun 288:690–696
43. Cui M, Klopot A, Jiang Y, Fleet JC (2009) The effect of differentiation on 1, 25 dihydroxyvi-
tamin D-mediated gene expression in the enterocyte-like cell line, CaCo-2. J Cell Physiol
218(1):113–121
44. Easwaran V, Pishvaian M, Salimuddin, Byers S (1999) Cross-regulation of beta-catenin-
LEF/TCF and retinoid signaling pathways. Curr Biol 9:1415–1418
45. Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance
M, Aranda A, Moras D, Norman A, Welsh J, Byers SW (2006) The molecular basis of vitamin
D receptor and beta-catenin crossregulation. Mol Cell 21:799–809
46. Larriba MJ, Valle N, Palmer HG, Ordonez-Moran P, Alvarez-Diaz S, Becker KF, Gamallo C,
de Herreros AG, Gonzalez-Sancho JM, Munoz A (2007) The inhibition of Wnt/beta-catenin
signalling by 1alpha, 25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer
cells. Endocr Relat Cancer 14:141–151
47. Pendas-Franco N, Garcia JM, Pena C, Valle N, Palmer HG, Heinaniemi M, Carlberg C, Jimenez
B, Bonilla F, Munoz A, Gonzalez-Sancho JM (2008) DICKKOPF-4 is induced by TCF/beta-
catenin and upregulated in human colon cancer, promotes tumour cell invasion and angio-
genesis and is repressed by 1alpha, 25-dihydroxyvitamin D3. Oncogene 27:4467–4477
48. Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morpho-
genesis. Cell 84:345–357
49. Wilson AJ, Velcich A, Arango D, Kurland AR, Shenoy SM, Pezo RC, Levsky JM, Singer
RH, Augenlicht LH (2002) Novel detection and differential utilization of a c-myc transcrip-
tional block in colon cancer chemoprevention. Cancer Res 62:6006–6010
50. Huang YC, Chen JY, Hung WC (2004) Vitamin D3 receptor/Sp1 complex is required for the
induction of p27Kip1 expression by vitamin D3. Oncogene 23:4856–4861
51. Zinser GM, Suckow M, Welsh J (2005) Vitamin D receptor (VDR) ablation alters carcinogen-
induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem
Mol Biol 97:153–164
52. Welsh J (2004) Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr
80:1721S–1724S
53. Escaleira MT, Brentani MM (1999) Vitamin D3 receptor (VDR) expression in HC-11 mam-
mary cells: regulation by growth-modulatory agents, differentiation, and Ha-Ras transforma-
tion. Breast Cancer Res Treat 54:123–133
54. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, Aguilera O, Steinmeyer A, Gamallo C,
Berciano MT, Lafarga M, Munoz A (2007) Vitamin D regulates the phenotype of human
breast cancer cells. Differentiation 75:193–207
55. Agadir A, Lazzaro G, Zheng Y, Zhang XK, Mehta R (1999) Resistance of HBL100 human
breast epithelial cells to vitamin D action. Carcinogenesis 20:577–582
56. Valrance ME, Brunet AH, Welsh J (2007) Vitamin D receptor-dependent inhibition of mam-
mary tumor growth by EB1089 and ultraviolet radiation in vivo. Endocrinology 148:4887–4894
57. Byrne B, Welsh J (2007) Identification of novel mediators of Vitamin D signaling and 1,
25(OH) D3 resistance in mammary cells. J Steroid Biochem Mol Biol 103:703–707
2
58. Wang Q, Lee D, Sysounthone V, Chandraratna RAS, Christakos S, Korah R, Wieder R (2001)
1, 25-dihydroxyvitamin D3 and retinoic acid analogues induce differentiation in breast cancer
cells with function- and cell-specific additive effects. Breast Cancer Res Treat 67:157–168
59. Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M, Welsh J (1997) Comparative
effects of 1, 25(OH) D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast
2
cancer cells. Breast Cancer Res Treat 42:31–41
60. Byrne BM, Welsh J (2005) Altered thioredoxin subcellular localization and redox status in
MCF-7 cells following 1, 25-dihydroxyvitamin D3 treatment. J Steroid Biochem Mol Biol
97:57–64
61. Li QP, Qi X, Pramanik R, Pohl NM, Loesch M, Chen G (2007) Stress-induced c-Jun-depen-
dent Vitamin D receptor (VDR) activation dissects the non-classical VDR pathway from the
classical VDR activity. J Biol Chem 282:1544–1551